login

Primarily engaged in detecting drug activity in neuropathic pain by selective nerve fiber signal assay in pre-clinical and clinical studies

Primarily engaged in detecting drug activity in neuropathic pain by selective nerve fiber signal assay in pre-clinical and clinical studies

In vivo electrode traces establish a benchmark index for each subject and monitor the incidence of ectopia in patients with neuropathic pain

In vivo electrode traces establish a benchmark index for each subject and monitor the incidence of ectopia in patients with neuropathic pain

Continued ectopia in the presence of drug substance indicates a lack of effect, attenuation shows evidence of effectiveness

Continued ectopia in the presence of drug substance indicates a lack of effect, attenuation shows evidence of effectiveness

Frontpage Slideshow | Copyright © 2006-2010 JoomlaWorks, a business unit of Nuevvo Webware Ltd.

NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.


We use microneurography to quantify spontaneous activity in pain fibers, both in patients and in human and animal models of painful conditions. This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.